An anti-COVID nasal spray, an innovation jointly developed by Health Systems Research Institute (HSRI), the Faculty of Medicine at Chulalongkorn University, the Government Pharmaceutical Organization (GPO) and Hibiocy Company, will be commercially available from October 1st. Dr. Nopporn Cheanklin, director of the PHRI, said today (Tuesday) that the Anti-COVID nasal spray, trade-name “Vaill CoviTRAP”, has…